Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

Mantle cell lymphoma (MCL) is still considered incurable and the course of the disease is highly variable. Established risk factors include the Mantle Cell Lymphoma International Prognostic Index (MIPI) and the quantification of the proliferation rate of the tumour cells, e.g. by Ki-67 immunohistoch...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Haematol
Asıl Yazarlar: Rauert-Wunderlich, Hilka, Mottok, Anja, Scott, David W., Rimsza, Lisa M., Ott, German, Klapper, Wolfram, Unterhalt, Michael, Kluin-Nelemans, Hanneke C., Hermine, Olivier, Hartmann, Sylvia, Thorns, Christoph, Rymkiewicz, Grzegorz, Holte, Harald, Dreyling, Martin, Hoster, Eva, Rosenwald, Andreas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6361690/
https://ncbi.nlm.nih.gov/pubmed/30095158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15519
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller